Propanc Biopharma PPCB
NASDAQ PPCB
$0.32 0.00 (-1.12%)
As of: Oct 21, 2026 · 3:03 PM EDT

Propanc Biopharma (PPCB) EPS (Diluted) (2022 - 2025)

Updated

Propanc Biopharma's EPS (Diluted) came in at -$17.62 for FY2026 (year ended Jun 30, 2026), compared with -$371.22 in FY2025.

Analysis

Propanc Biopharma (PPCB) EPS (Diluted) (2022 - 2025) Analysis & Trends

Going back to FY2022, Propanc Biopharma's EPS (Diluted) data covers 5 fiscal years.

  • The five-year range for annual EPS (Diluted) is -$1,231 (FY2022) to -$0.59 (FY2024).
  • Per Business Quant, earlier fiscal years put EPS (Diluted) at -$371.22 in FY2025, -$0.59 in FY2024, -$44.96 in FY2023 and -$1,231 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Eli Lilly 1,136.62 Bn 1,105.21 Bn 19.71 Bn 7.94
2 Johnson & Johnson 617.59 Bn 536.12 Bn 17.26 Bn 2.27
3 AbbVie 501.69 Bn 474.80 Bn 12.70 Bn 2.04
4 Merck 368.29 Bn 322.67 Bn 12.21 Bn -0.54
5 Novartis Ag 297.79 Bn 261.78 Bn 11.24 Bn 1.67
6 Astrazeneca 260.82 Bn 234.50 Bn 12.86 Bn 1.60
7 Amgen 236.53 Bn 191.93 Bn 7.24 Bn 4.37
8 Gilead Sciences 191.14 Bn 165.33 Bn 6.22 Bn -8.44
9 Pfizer 169.69 Bn 116.33 Bn 10.94 Bn -0.04
10 Propanc Biopharma 356,665.25 -1.65 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -7.53
Sep 30, 2025 -9.81
Jun 30, 2025 -25.65
Mar 31, 2025 -312.46
Dec 31, 2024 -805.59
Sep 30, 2024 -0.01
Jun 30, 2024 -0.11
Mar 31, 2024 -0.23
Dec 31, 2023 -0.65
Sep 30, 2023 -1.12
Jun 30, 2023 -11.59
Mar 31, 2023 -10.52
Dec 31, 2022 -13.14
Sep 30, 2022 -53.13
Jun 30, 2022 -424.87
API Access

Propanc Biopharma EPS (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=eps-diluted&ticker=PPCB&period=max&api_key=YOUR_API_KEY